Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
about
Placebos without deception: a randomized controlled trial in irritable bowel syndromeHypnotherapy for treatment of irritable bowel syndromeComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndromeIrritable bowel syndromeIrritable bowel syndrome.Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot studyTherapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.Evaluation of the Birmingham IBS symptom questionnaireComplementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndromeDevelopment of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales.Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.Importance of early diagnosis in patients with irritable bowel syndrome.Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel diseaseText messaging: an innovative method of data collection in medical research.Familial aggregation of irritable bowel syndrome: a family case-control study.Stomach antral endocrine cells in patients with irritable bowel syndrome.Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.Predictors of patient-assessed illness severity in irritable bowel syndrome.Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.Effect of korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective oA protocol for a trial of homeopathic treatment for irritable bowel syndrome.Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.Health-related quality of life of irritable bowel syndrome patients in different cultural settings.Health-related quality of life among persons with irritable bowel syndrome: a systematic review.Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.Biopsychosocial model of irritable bowel syndrome.Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study.Quality of life in gastric cancer.
P2860
Q21091076-0E890B13-2470-4B5D-8682-40827B1395E3Q24243478-0C105318-10CE-4E9B-8BCB-EABA1C9C3D94Q24647883-C7CF43E7-7BBB-425A-BB21-E2E2A2F5C7B2Q27010213-C54285A5-F41B-4791-91AE-5AD972C1FAA4Q27687723-2802AEA3-2918-4AFE-9626-8F7E7DBF29E9Q28543828-C95D6534-8BC4-4E9C-B544-66226B628914Q30444653-723D4369-7560-4D30-834C-E08AEB582949Q30497606-1BDBA0AD-1FFA-47F5-8435-19C0F44A972CQ30565579-124AA54B-A35B-4CDC-B011-D8F73CF81A67Q33354600-07E55DA4-647D-4608-B60A-128191E6FA71Q33354789-1FC5A398-DC01-4D61-865B-EC73CF56C963Q33409756-07109A46-E1C0-47A7-8C42-7E64432940B0Q33462837-FD11A68D-52E2-48F1-A55A-FA0294CBC66FQ33468410-F623D55F-6A1D-4390-ADB0-65DE0ADFBFC6Q33470217-D24D7644-ABA0-40B7-9BF7-B324BA5C7694Q33488090-ECB5227F-4F5F-4BEF-A4FE-CC6A0101764EQ33536973-5CD60CBE-2EB7-4488-92FC-47C39FED11A9Q33578024-DD570B26-DEBE-43F3-937C-80450CCF0351Q33636450-2016D241-4A85-4B8A-BF75-71EC5C5CC531Q33696448-4B31D542-E12A-4C41-8ED4-99EC81C7F5EDQ33776203-15BE367F-8E47-4C6F-BE92-4B54D9E1B834Q33872002-9FA53A58-3966-4354-A2F9-30F3141DEDE1Q34121823-6B712F11-C416-44AE-A9D6-370E3D51059DQ34165056-22217B37-4F0E-45FF-BDD8-D9B8C3001711Q34170665-5E342032-75D5-4667-A650-49DBFEA8876BQ34303061-4727B031-5025-4AB4-B99B-7556639D0F8FQ34308383-B9565B26-0096-4979-B4DC-5A59DEA532C1Q34392861-C2B51EF5-53BF-4C51-AC4F-F07158008191Q34395120-5155C534-BBD3-40C9-BC4F-88FFB3992F66Q34410818-55EFDDA2-DC90-47F3-AC78-23612DE1441BQ34468338-4E900F2E-08B9-472D-8DCF-26F4A7ADC517Q34552117-AD07BA30-4BF4-4DEB-A77A-1019C3837712Q34557291-61F40A8A-CF96-44F3-B383-5544DC85C8D6Q34657373-C1929394-CFC8-4197-A6B5-6553F4DB1881Q34678617-586CA9CB-B8E9-4FD3-AA42-55838697D337Q34764154-7CD72073-70DB-4613-BE2F-FA348FE01379Q34786704-E710A08B-5994-4FC2-840E-62CE56223C1FQ34976207-9E2D5FFD-868C-4504-AD20-B60CCC9A18AEQ34994382-1237A084-705B-4256-BEEF-B711BB240AB0Q35045572-531B4623-7A2D-4C71-8D70-7E3FF3DB7371
P2860
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@en
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@nl
type
label
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@en
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@nl
prefLabel
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@en
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@nl
P2093
P1476
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
@en
P2093
Bangdiwala SI
Diamant NE
Drossman DA
Patrick DL
Whitehead WE
P2860
P304
P356
10.1111/J.1572-0241.2000.01941.X
P407
P577
2000-04-01T00:00:00Z